About Avant Diagnostics
Avant Diagnostics is a company based in Phoenix (United States) founded in 2009. Avant Diagnostics has completed 1 acquisition, including Theranostics Health. Avant Diagnostics offers products and services including Live Draw Macau and Data Macau. Avant Diagnostics operates in a competitive market with competitors including AOA, GenoME Diagnostics, Aspira Women's Health, KOKO Medical and VOC Diagnostics, among others.
- Headquarter Phoenix, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$650 K (USD), Post-IPO
May 30, 2018
-
Investors
Not available
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Avant Diagnostics
Avant Diagnostics offers a comprehensive portfolio of products and services, including Live Draw Macau and Data Macau.
Real-time platform for viewing Toto Macau draws and results
Comprehensive tables of past and current lottery data updates
People of Avant Diagnostics
Unlock access to complete
Leadership Team
8 people
Chairman Team
3 people
Advisor Team
1 people
Sales and Marketing
1 people
Unlock access to complete
Funding Insights of Avant Diagnostics
Investments & Acquisitions by Avant Diagnostics
Avant Diagnostics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Theranostics Health.
Investment portfolio details for Avant Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Proteomic-based molecular diagnostic tests for guiding personalized cancer therapy.
|
Locked | Locked | 2006 | Locked |
Complete acquisition details for Avant Diagnostics
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Avant Diagnostics
Detailed financials for Avant Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Avant Diagnostics Comparisons
Peer comparison for Avant Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Avant Diagnostics
Avant Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AOA, GenoME Diagnostics, Aspira Women's Health, KOKO Medical and VOC Diagnostics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Business consultancy services are provided for the biopharma industry.
|
|
| Locked | Locked | Locked |
An in-vitro diagnostic test for ovarian cancer is developed.
|
|
| Locked | Locked | Locked |
Diagnostic solutions for ovarian cancer risk in women are provided.
|
|
| Locked | Locked | Locked |
Postpartum hemorrhage addressed by catheter-based medical device for women.
|
|
| Locked | Locked | Locked |
Developer of diagnostic solutions to detect ovarian cancer
|
Detailed competitors of Avant Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Avant Diagnostics
Complete news archive for Avant Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Avant Diagnostics
Avant Diagnostics was founded in 2009 and raised its 1st funding round 7 years after it was founded.
Avant Diagnostics is headquartered in Phoenix, United States. It is registered at Phoenix, Arizona, United States.
Avant Diagnostics was founded in 2009 as a spin-off of Arrayit Corporation in Phoenix, United States. Diagnostic tests for early cancer detection are developed using microarray technology. The OvaDx test, which identifies proteomic biomarkers in blood for ovarian cancer stages IA-IV, is awaiting FDA approval. In January 2016, Amarantus Diagnostics was acquired, incorporating neurological diagnostic tests into operations within the biotechnology sector.
Avant Diagnostics's top competitors include Aspira Women's Health, AOA and KOKO Medical.
Avant Diagnostics offers Live Draw Macau and Data Macau.
Avant Diagnostics has made 1 acquisition, including Theranostics Health.